Scarica l'app Stockscreener
1.23
3.36%
0.04
Dopo l'orario di chiusura:
1.21
-0.02
-1.63%
Lucid Diagnostics Inc Borsa (LUCD) Ultime notizie
How analysts rate Lucid Diagnostics Inc. stock today2025 Biggest Moves & Low Volatility Stock Recommendations - ulpravda.ru
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - MarketScreener
PAVMED announces 1-for-30 reverse stock split - MSN
PAVmed Announces Reverse Stock Split - marketscreener.com
PAVmed Announces Reverse Stock Split - Benzinga
Ideas Watch: Will Lucid Diagnostics Inc stock see PE expansionWeekly Investment Summary & AI Driven Stock Price Forecasts - moha.gov.vn
Bull Run: Why Lucid Diagnostics Inc stock remains on buy listsJuly 2025 Gainers & Community Verified Trade Signals - moha.gov.vn
Here’s Why Lucid Diagnostics (LUCD) Declined in Q3 - Insider Monkey
Lucid Diagnostics files for $175 mln mixed securities shelf offering - MSN
With Lucid Diagnostics Stock Surging, Have You Considered The Downside? - Trefis
Can Lucid Diagnostics Inc. stock reach $100 price targetJuly 2025 Momentum & Comprehensive Market Scan Reports - Улправда
What valuation multiples suggest for Lucid Diagnostics Inc. stockJuly 2025 WrapUp & Smart Allocation Stock Tips - DonanımHaber
Can Lucid Diagnostics Inc. stock rebound after recent weakness2025 Trade Ideas & Free Safe Capital Growth Stock Tips - DonanımHaber
Brokerages Set Lucid Diagnostics Inc. (NASDAQ:LUCD) Price Target at $3.94 - Defense World
Lucid Group stock hits 52-week low at $11.46 - Investing.com
Lucid Diagnostics Earnings Notes - Trefis
Can Lucid Diagnostics Inc stock rebound after recent weakness2025 Top Decliners & Verified Momentum Stock Ideas - moha.gov.vn
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is Lucid Diagnostics (NASDAQ:LUCD) Using Too Much Debt? - simplywall.st
Ascendiant Capital Markets Issues Positive Forecast for Lucid Diagnostics (NASDAQ:LUCD) Stock Price - Defense World
Lucid Diagnostics Stock (LUCD) Opinions on Recent Clinical Data Release - Quiver Quantitative
Lucid Diagnostics (NASDAQ:LUCD) Given New $8.25 Price Target at Ascendiant Capital Markets - MarketBeat
LUCD FinancialsIncome Statement - Quiver Quantitative
Ascendiant Capital Maintains Lucid Diagnostics (LUCD) Buy Recommendation - Nasdaq
Lucid Diagnostics stock price target raised to $8.25 at Ascendiant Capital By Investing.com - Investing.com South Africa
Lucid Diagnostics stock price target raised to $8.25 at Ascendiant Capital - Investing.com Canada
Lucid Diagnostics files $175M mixed securities shelf - MSN
Lucid Diagnostics reports real-world data on esophageal test device By Investing.com - Investing.com Australia
Lucid Diagnostics (LUCD) Stock: Surge After Real-World EsoGuard Data Breakthrough! - parameter.io
Lucid Diagnostics reports real-world data on esophageal test device - Investing.com
Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection - PR Newswire
Lucid Diagnostics (Nasdaq: LUCD) reports 95% EsoCheck success in 11,991 patients - Stock Titan
Lucid Diagnostics Announces $15.3 Million Registered Direct Offe - GuruFocus
A Look at Lucid Diagnostics Inc (LUCD) Shares in the Recent Past Indicates Growth - Setenews
Should I hold or sell Lucid Diagnostics Inc. stock in 2025Weekly Market Outlook & Weekly High Return Stock Opportunities - Newser
Is Lucid Diagnostics, Inc. overvalued or undervalued? - Markets Mojo
Why Lucid Diagnostics Inc. stock appeals to analysts2025 Retail Activity & Safe Investment Capital Preservation Plans - Newser
Lucid Diagnostics (LUCD) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Lucid Diagnostics stock falls after pricing capital raise of $15M via stock offering - MSN
Lucid Diagnostics Inc.'s (NASDAQ:LUCD) largest shareholders are individual investors with 38% ownership, public companies own 30% - Yahoo Finance
Is Lucid Diagnostics Inc (LUCD) positioned for future growth? - Setenews
Why Being Public Gave PavMed a Competitive Edge - Medical Device and Diagnostic industry
Get in on Lucid Diagnostics Inc’s (LUCD) buy-in window today! - Setenews
Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree - PR Newswire
Ranking Lucid Diagnostics Inc. among high performing stocks via tools2025 Top Decliners & AI Powered Trade Plan Recommendations - newser.com
Lucid Diagnostics stock maintains Overweight rating at Cantor Fitzgerald By Investing.com - Investing.com Canada
Developing predictive dashboards with Lucid Diagnostics Inc. dataBear Alert & Fast Gain Swing Alerts - newser.com
Lucid Diagnostics stock maintains Overweight rating at Cantor Fitzgerald - Investing.com
2.10%
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):